Atsushi Suzuki

Fujisawa, 2518555, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant.

Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant.

Journal: Neuropharmacology

Published: September 17, 2022

TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.

TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.

Journal: Pharmacology, biochemistry, and behavior

Published: August 02, 2021

Author Correction: Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement.

Author Correction: Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement.

Journal: Scientific reports

Published: July 22, 2021

Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement.

Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement.

Journal: Scientific reports

Published: April 23, 2021

TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice.

TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice.

Journal: Pharmacology, biochemistry, and behavior

Published: September 11, 2019

Electrophysiological characterization of a novel AMPA receptor potentiator, TAK-137, in rat hippocampal neurons.

Electrophysiological characterization of a novel AMPA receptor potentiator, TAK-137, in rat hippocampal neurons.

Journal: Neuroscience letters

Published: May 31, 2019

TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.

TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.

Journal: Pharmacology, biochemistry, and behavior

Published: April 01, 2019

TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects.

TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: April 04, 2018

TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window.

TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: April 02, 2018

Effects of Long-Term Treatment with Levetiracetam as an Adjunctive Therapy in Japanese Children with Uncontrolled Partial-Onset Seizures: A Multicenter, Open-Label Study

Effects of Long-Term Treatment with Levetiracetam as an Adjunctive Therapy in Japanese Children with Uncontrolled Partial-Onset Seizures: A Multicenter, Open-Label Study

Journal: Brain and nerve = Shinkei kenkyu no shinpo

Published: November 13, 2015

Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.

Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.

Journal: Psychiatry and clinical neurosciences

Published: October 31, 2014

Efficacy and safety of levetiracetam as adjunctive therapy in Japanese children with uncontrolled partial-onset seizures: multicenter and open-label study (N01223), short term evaluation

Efficacy and safety of levetiracetam as adjunctive therapy in Japanese children with uncontrolled partial-onset seizures: multicenter and open-label study (N01223), short term evaluation

Journal: Brain and nerve = Shinkei kenkyu no shinpo

Published: September 11, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026